Pathogenic properties of the N-terminal region of cardiac myosin binding protein-C in vitro

被引:0
作者
Suresh Govindan
Jason Sarkey
Xiang Ji
Nagalingam R. Sundaresan
Mahesh P. Gupta
Pieter P. de Tombe
Sakthivel Sadayappan
机构
[1] Loyola University Chicago,Department of Cell and Molecular Physiology, Stritch School of Medicine
[2] University of Chicago,Department of Surgery
来源
Journal of Muscle Research and Cell Motility | 2012年 / 33卷
关键词
Proteolysis; Pathogenesis; Muscle contractility; Actin; Acetylation; Ca; Transients;
D O I
暂无
中图分类号
学科分类号
摘要
Cardiac myosin binding protein-C (cMyBP-C) plays a role in sarcomeric structure and stability, as well as modulating heart muscle contraction. The 150 kDa full-length (FL) cMyBP-C has been shown to undergo proteolytic cleavage during ischemia–reperfusion injury, producing an N-terminal 40 kDa fragment (mass 29 kDa) that is predominantly associated with post-ischemic contractile dysfunction. Thus far, the pathogenic properties of such truncated cMyBP-C proteins have not been elucidated. In the present study, we hypothesized that the presence of these 40 kDa fragments is toxic to cardiomyocytes, compared to the 110 kDa C-terminal fragment and FL cMyBP-C. To test this hypothesis, we infected neonatal rat ventricular cardiomyocytes and adult rabbit ventricular cardiomyocytes with adenoviruses expressing the FL, 110 and 40 kDa fragments of cMyBP-C, and measured cytotoxicity, Ca2+ transients, contractility, and protein–protein interactions. Here we show that expression of 40 kDa fragments in neonatal rat ventricular cardiomyocytes significantly increases LDH release and caspase 3 activity, significantly reduces cell viability, and impairs Ca2+ handling. Adult cardiomyocytes expressing 40 kDa fragments exhibited similar impairment of Ca2+ handling along with a significant reduction of sarcomere length shortening, relaxation velocity, and contraction velocity. Pull-down assays using recombinant proteins showed that the 40 kDa fragment binds significantly to sarcomeric actin, comparable to C0–C2 domains. In addition, we discovered several acetylation sites within the 40 kDa fragment that could potentially affect actomyosin function. Altogether, our data demonstrate that the 40 kDa cleavage fragments of cMyBP-C are toxic to cardiomyocytes and significantly impair contractility and Ca2+ handling via inhibition of actomyosin function. By elucidating the deleterious effects of endogenously expressed cMyBP-C N-terminal fragments on sarcomere function, these data contribute to the understanding of contractile dysfunction following myocardial injury.
引用
收藏
页码:17 / 30
页数:13
相关论文
共 250 条
[1]  
Barefield D(2010)Phosphorylation and function of cardiac myosin binding protein-C in health and disease J Mol Cell Cardiol 48 866-875
[2]  
Sadayappan S(2009)During muscle atrophy, thick, but not thin, filament components are degraded by MuRF1-dependent ubiquitylation J Cell Biol 185 1083-1095
[3]  
Cohen S(2002)Functional consequences of caspase activation in cardiac myocytes Proc Natl Acad Sci USA 99 6252-6256
[4]  
Brault JJ(2010)Analysis of cardiac myosin binding protein-C phosphorylation in human heart muscle J Mol Cell Cardiol 49 1003-1011
[5]  
Gygi SP(2005)Myosin-binding protein C phosphorylation, myofibril structure, and contractile function during low-flow ischemia Circulation 111 906-912
[6]  
Glass DJ(1996)A molecular map of the interactions between titin and myosin-binding protein C. Implications for sarcomeric assembly in familial hypertrophic cardiomyopathy Eur J Biochem 235 317-323
[7]  
Valenzuela DM(2009)Top-down high-resolution mass spectrometry of cardiac myosin binding protein C revealed that truncation alters protein phosphorylation state Proc Natl Acad Sci USA 106 12658-12663
[8]  
Gartner C(1999)Identification of the A-band localization domain of myosin binding proteins C and H (MyBP-C, MyBP-H) in skeletal muscle J Cell Sci 112 69-79
[9]  
Latres E(2012)Cardiac myosin binding protein-C is a potential diagnostic biomarker for myocardial infarction J Mol Cell Cardiol 52 154-164
[10]  
Goldberg AL(1999)Mutations in beta-myosin S2 that cause familial hypertrophic cardiomyopathy (FHC) abolish the interaction with the regulatory domain of myosin-binding protein-C J Mol Biol 286 933-949